yue wang

Mr. yue wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in International Dental Journal
Verified
Journal Article
Open access
YWyue wang
yue wang
JZJingjing Zheng
Jingjing Zheng
WRWenhao Ren
Wenhao Ren
SLShaoming Li
Shaoming Li
KZKeqian Zhi
Keqian Zhi
LGLing Gao
Ling Gao
This study evaluates the global burden of head and neck cancers, analyzing incidence, mortality, and DALYs from 1990 to 2021, across age groups and regions with varying SDI levels. Data from the Global Burden of Disease (GBD) database (1990-2021) was utilized to examine incidence, mortality, and DALYs for head and neck cancers. Regional disease trends were analyzed using age-standardized rates (ASR), estimated annual percentage change (EAPC), Joinpoint regression, and the Age-Period-Cohort model. A global map depicted disease burden across 204 countries and territories, 21 GBD regions, and 5 SDI regions. In 2021, there were 421,577 new lip and oral cavity cancer cases and 208,379 deaths, with DALYs totaling 5,874,070 years. EAPC results indicated rising incidence for lip and oral cavity cancers (EAPC: 0.4% [95% CI: 0.33-0.46]) and other pharyngeal cancers (EAPC: 0.68% [95% CI: 0.6-0.75]). The AAPC model showed an overall increase in incidence for lip and oral cavity cancers (AAPC: 0.442 [0.374-0.511]) and other pharyngeal cancers (AAPC: 0.716 [0.607-0.826]). While mortality rates remained stable or declined. Lip and oral cavity cancer incidence rose most in the middle SDI region, followed by low-middle and low SDI regions, while other pharyngeal cancers saw the highest increase in high, low-middle, and low SDI regions. The AAPC model indicated a declining incidence for lip and oral cavity cancers in all regions except the high SDI region (AAPC: -0.012 [-0.17-0.147]), where other pharyngeal cancers had the highest increase (AAPC: 1.034 [0.741-1.329]). Mortality for lip and oral cavity cancers rose in low-middle SDI regions, while other pharyngeal cancers showed increased mortality in low-middle and low SDI regions. South Asia reported the highest incidence, mortality, and DALYs for lip, oral cavity, and oropharyngeal cancers in 2021. Age-cohort analysis showed that incidence rose until age 55, stabilizing or declining afterward, while the burden of lip and oral cavity cancers increased after 55, with mortality highest over 80. Head and neck cancer burden is concentrated in low- and middle-income countries, highlighting the need for prevention, early screening, risk factor control, and improved data monitoring in low-income regions.

16 December 2023 in International Dental Journal
Verified
Journal Article
Open access
YWyue wang
yue wang
FWFang Wang
Fang Wang
SWShuhan Wang
Shuhan Wang
LZLingnan Zhang
Lingnan Zhang
HFHonghai Fu
Honghai Fu
XMXiangrui Ma
Xiangrui Ma
The present study aimed to explore the expression and clinical significance of human papilloma virus-related pathogenic factors (p16, cyclin D1, p53) in patients with head and neck squamous cell carcinoma (HNSCC) and construct a predictive model. The Cancer Genome Atlas was used to obtain clinical data for 112 patients with HNSCC. Expression of p16, p53, and cyclin D1 was quantified. We used the survival package of the R program to set the cut-off value. Values above the cut-off were considered positive, while values below the cut-off were negative. Kaplan-Meier analysis and univariate and multivariate Cox regression analyses were performed to investigate prognostic clinicopathological indicators and the expression of p16, p53, and cyclin D1. A predictive model was constructed based on the results of multifactor Cox regression analysis, and the accuracy of the predictive model was verified through final calibration analysis. Follow-up of patients with HNSCC at the Affiliated Hospital of Binzhou Medical University was conducted from 2015 to 2017, and reliability of the predictive model was validated based on follow-up data and molecular expression levels. According to the results, expression of p16 and p53 was significantly associated with prognosis (P < .05). The predictive model constructed based on the expression levels of p16 and p53 was useful for evaluating the prognosis of patients with HNSCC. The predictive model was validated using follow-up data obtained from the hospital, and the trend of the follow-up results was consistent with the predictive model. p16 and p53 can be used as key indicators to predict the prognosis of HNSCC patients and as critical immunohistochemical indicators in clinical practice. The survival model constructed based on p16 and p53 expression levels reliably predicts patient prognosis.

29 June 2022 in Oral Diseases
Verified
Journal Article
Closed access
YWyue wang
yue wang
XMXiangrui Ma
Xiangrui Ma
SWShuhan Wang
Shuhan Wang
ZLZhipeng Li
Zhipeng Li
FWFang Wang
Fang Wang
WWWenlong Wang
Wenlong Wang

18 June 2026 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
SWShuhan Wang
Shuhan Wang
YZYu Zhang
Yu Zhang
YDYamin Dong
Yamin Dong
GDGang Dong
Gang Dong
YWyue wang
yue wang
Neoadjuvant therapy has been increasingly explored as a treatment strategy for oral squamous cell carcinoma (OSCC) and may be associated with favorable pat

30 June 2025 in International Journal of Surgery
Verified
Journal Article
Open access
YSYao Shi
Yao Shi
XZXin Zhao
Xin Zhao
YWYuzhen Wen
Yuzhen Wen
YDYamin Dong
Yamin Dong
YWyue wang
yue wang
An abstract is unavailable. This article is available as a PDF only.